BeStock  
Stocks › Biotechnology › SGP

SpyGlass Pharma SGP

US equityMarket cap rank #3144Biotechnology
$30.43 −$0.35 (-1.14%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $30.43 0.00%
Open$30.12
Prev close$30.78
Day range$29.07 – $31.73
Volume108.9K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$26.25M-136.4% YoY
Net profit-$24.25M-147.1% YoY
Diluted EPS-$0.73-137.3% YoY
Free cash flow-$18.48M-105.5% YoY
Operating cash flow-$16.02M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-8.4MDec '24$-8.8MMar '25$-8.7MJun '25$-9.8MSep '25$-12.6MDec '25$-13.8MMar '26$-19.9MJun '26$-24.3MSep '26

Diluted EPS by quarter

-0.47Dec '24-0.49Mar '25-0.27Jun '25-0.31Sep '25-0.39Dec '25-0.69Mar '26-0.59Jun '26-0.73Sep '26

Free cash flow by quarter

$-6.7MDec '24$-8.4MMar '25$-6.4MJun '25$-9.0MSep '25$-9.8MDec '25$-14.2MMar '26$-16.8MJun '26$-18.5MSep '26

Annual revenue

$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-114.4%
Return on assets-39.9%
Return on invested capital-120.8%
Current ratio15.24
Liabilities / assets7.0%
Cash & investments$215.76M
Total debt$1.61M
Net cash (debt)$214.15M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Other Current Liabilities $6.14M $3.56M $2.27M $3.71M $3.71M
-Short Term Investments $7.07M $11.04M $12.10M $11.08M $11.08M
-Cash and Cash Equivalents $208.69M $223.14M $238.90M $96.36M $96.36M
Cash and Cash Equivalents & Short-Term Investments $215.76M $234.19M $251.00M $107.44M $107.44M
Total Current Assets $217.92M $236.46M $253.36M $108.77M $108.77M
Total Assets $226.35M $243.43M $258.39M $115.87M $115.87M
Receivables $574,000.00 $678,000.00 $653,000.00 $431,000.00 $431,000.00
Other Current Assets $1.58M $1.60M – – –
-Accounts Payable $5.65M $4.16M $3.51M $2.70M $2.70M
Payables $5.65M $4.16M $3.51M $2.70M $2.70M
Total Current Liabilities $14.30M $9.44M $6.67M $8.58M $8.58M
Total Liabilities $15.91M $11.07M $8.27M $214.70M $214.70M
Other Non-Current Assets $689,000.00 $759,000.00 $789,000.00 $492,000.00 $492,000.00
Non-Current Deferred Assets $0.00 $0.00 $0.00 $2.72M $2.72M
-Accumulated Depreciation -$1.35M -$1.77M -$1.43M -$1.11M -$1.11M
-Gross PPE $9.10M $7.99M $5.67M $5.01M $5.01M
Net PPE $7.75M $6.21M $4.24M $3.89M $3.89M
Total Non-Current Assets $8.43M $6.97M $5.02M $7.10M $7.10M
-Other Receivables $574,000.00 $678,000.00 $653,000.00 $431,000.00 $431,000.00
Long Term Debt and Capital Lease Obligation $1.61M $1.63M $1.61M $1.58M $1.58M
Capital Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $0.00
Total Non-Current Liabilities $1.61M $1.63M $1.61M $206.12M $206.12M
Additional Paid-In Capital $373.11M $370.78M $368.66M $5.89M $5.89M
Total Equity $210.44M $232.36M $250.11M -$98.84M -$98.84M
Stockholders' Equity $210.44M $232.36M $250.11M -$98.84M -$98.84M
Retained Earnings -$162.67M -$138.41M -$118.55M -$104.73M -$104.73M
Convertible preferred securities $0.00 $0.00 $0.00 $204.54M $204.54M
-Long Term Capital Lease Obligation $1.61M $1.63M $1.61M $1.58M $1.58M
-Preferred Stock $0.00 $0.00 $0.00 – –
Prepaid Assets – – $1.71M $901,000.00 $901,000.00
-Current Capital Lease Obligation – – – $0.00 $0.00

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Basic EPS -$0.73 -$0.59 -$0.69 -$0.39 -$1.25
Diluted EPS -$0.73 -$0.59 -$0.69 -$0.39 -$1.25
Profit from Continuing Operations -$24.25M -$19.86M -$13.82M -$12.56M -$39.87M
Non-Operating Interest Income $1.99M $2.10M $1.59M $1.07M $3.11M
Net Non-Operating Interest Income (Expense) $1.99M $2.10M $1.59M $1.07M $3.11M
Operating Profit -$26.25M -$21.97M -$15.41M -$13.63M -$41.45M
Research & Development $10.03M $10.94M $8.54M $7.71M $29.18M
-General & Admin Expense $16.21M $11.03M $6.87M $5.92M $12.27M
Selling and Admin Expenses $16.21M $11.03M $6.87M $5.92M $12.27M
Operating Expense $26.25M $21.97M $15.41M $13.63M $41.45M
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Net Income to Parent Company -$24.25M -$19.86M -$13.82M -$12.56M -$39.87M
Pretax Profit -$24.25M -$19.86M -$13.82M -$12.56M -$39.87M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Income to Common Stockholders -$24.25M -$19.86M -$13.82M -$12.56M -$39.87M
Net Profit -$24.25M -$19.86M -$13.82M -$12.56M -$39.87M
Other Non-Operating Income (Expenses) – – – $0.00 -$1.53M
Other Income (Expense) – – – $0.00 -$1.53M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Free Cash Flow -$18.48M -$16.77M -$14.22M -$9.76M -$33.49M
Beginning Cash Balance $223.14M $238.90M $96.36M $106.01M $16.27M
Net Change in Cash -$14.46M -$15.76M $142.54M -$9.65M $80.09M
Ending Cash Balance $208.69M $223.14M $238.90M $96.36M $96.36M
-Change in Payables and Accrued Expense $2.30M $1.61M -$347,000.00 $3.59M $3.12M
-Change in Prepaid Assets $15,000.00 $109,000.00 -$805,000.00 $338,000.00 -$186,000.00
-Change in Receivables $104,000.00 -$25,000.00 -$222,000.00 -$13,000.00 -$8,000.00
Change in Working Capital $5.65M $2.48M -$1.75M $2.56M $2.45M
Other Non-Cash Items -$3,000.00 $120,000.00 $32,000.00 -$480,000.00 -$209,000.00
Depreciation & Depletion & Amortization $280,000.00 $342,000.00 $318,000.00 $217,000.00 $612,000.00
Net Income from Continuing Operations -$24.25M -$19.86M -$13.82M -$12.56M -$39.87M
Net cash flow from continuing operations -$16.02M -$14.84M -$13.54M -$9.34M -$32.70M
Operating Cash Flow -$16.02M -$14.84M -$13.54M -$9.34M -$32.70M
-Change in Other Current Assets $71,000.00 $30,000.00 -$298,000.00 -$14,000.00 -$38,000.00
-Change in Other Current Liabilities $3.16M $759,000.00 -$79,000.00 -$1.34M -$441,000.00
Net Other Financing Charges $0.00 -$18,000.00 -$2.73M -$909,000.00 -$1.47M
Proceeds from Stock Option Exercised $27,000.00 $31,000.00 $55,000.00 $21,000.00 $170,000.00
Net Preferred Stock Issuance $0.00 $0.00 $0.00 $0.00 $127.34M
Net Common Stock Issuance $0.00 $0.00 $160.43M $0.00 -$1.45M
Net Cash Flow from Continuing Financing Activities $27,000.00 $13,000.00 $157.76M -$888,000.00 $124.59M
Financing Cash Flow $27,000.00 $13,000.00 $157.76M -$888,000.00 $124.59M
Net Investment Purchase and Sale $4.00M $999,000.00 -$991,000.00 $995,000.00 -$11.01M
Net PPE Purchase and Sale -$2.46M -$1.93M -$676,000.00 -$421,000.00 -$789,000.00
Net Cash Flow from Continuing Investing Activities $1.54M -$933,000.00 -$1.67M $574,000.00 -$11.79M
Net cash flow from investing $1.54M -$933,000.00 -$1.67M $574,000.00 -$11.79M
Gain/Loss from Continuing Operations – – – $1,000.00 $5,000.00

Discussion

No comments yet — be the first to weigh in on SGP.

Sign in to join the discussion.

Scroll to Top